Asset Dedication’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Asset Dedication's MRNA Position: Q3 2026 in Review
Asset Dedication reduced its Moderna (MRNA) stake by 33% in Q3 2026, selling an estimated $29.6K and leaving 568 shares worth $109K. The position accounts for 0.01% of the portfolio, ranked #387.
Asset Dedication first reported a position in MRNA in Q2 2020 and has held it in 26 quarters since. The position peaked at $292K in Q3 2021. 858 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Asset Dedication held 568 shares of Moderna worth $109K as of Q3 2026.
- Asset Dedication sold 275 Moderna shares in Q3 2026, an estimated $29.6K.
- Moderna made up 0.01% of Asset Dedication's portfolio in Q3 2026, its #387 holding.
- Asset Dedication first reported a position in Moderna in Q2 2020 and has held it in 26 quarters since.
- Asset Dedication's Moderna position peaked at $292K in Q3 2021.
- 858 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Asset Dedication's 13F filing for Q3 2026, filed 3 Nov 2026.